Practical considerations for the use of catheter-directed thrombolysis in deep vein thrombosis
Vascular Investigation and Therapy · 2024
DOI: 10.4103/vit.vit-d-23-00007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Vascular Investigation and Therapy, 2024. Verfasst von Saurabh Kumar Rai und 1 weiteren Autor:innen. Die Arbeit nennt 12 Literaturangaben.
Themen: Thromboseprophylaxe
Abstract (Originalsprache)
Dear Editor, Catheter-directed thrombolysis (CDT) is a minimal invasive endovascular treatment for acute deep vein thrombosis (DVT) as an adjunct to anticoagulation. CDT reduces the risk for postthrombotic syndrome (PTS) by early recanalization of DVT by preventing damage that could occur to the valve of deep vein due to chronic thrombosis.[1] Herein, we have a brief review of the indications, contraindications, and procedural aspects of CDT. CDT is an image-guided therapy, in which thrombolytic drug is infused directly in the thrombosed segment of deep vein through multiple side-hole catheters and concomitant intravenous or oral anticoagulants are also given. Rational for the use of CDT along with anticoagulation includes:[2,3] Patients with lower limb DVT are at particularly high risk for PTS and late disability Anticoagulant-only therapy fails to prevent PTS in a large proportion of patients with acute proximal DVT CDT decreases the risk of systemic toxicity and the total dose of thrombolytic drug by maintaining the optimum dose at the site of thrombosis CDT has significant potential to prevent PTS and offers distinct advantages compared with surgical venous thrombectomy, systemic thrombolysis, and anticoagulation alone Adjunctive CDT is likely to provide faster symptom relief than anticoagulation alone and does not increase the risk of symptomatic pulmonary embolism (PE).[4] Indication: The Society of Interventional Radiology recommends CDT for:[5] Extensive thrombosis with high risk of PE Proximal DVT (iliofemoral or femoral vein) Acute proximal DVT in ambulatory patients with low bleeding risk and long life expectancy Highly symptomatic subacute and chronic proximal DVT Acute or subacute inferior vena cava (IVC) thrombosis Limb-threatening conditions such as phlegmasia cerulea dolens.[5] Contraindications for the use of CDT are:[6] Active internal bleeding Patient age >70 years Recent ( 180 mmHg.[6] Hardware required in CDT includes:[7] An 18 G puncture needle A 5 or 6 F sheath J-tip 0.035” hydrophilic guidewires 5 F (pigtail) infusion catheter with multiple side holes Thrombolysis therapy/medication An infusion system for the pharmacotherapies.[7] Preprocedure workup of patient must include:[2] Obtain detail clinical history, past surgical history, and present medication taken by the patient. Physical examination should be done to assess the severity of the disease. Rule out pregnancy in a female patient Informed and written consent should be taken preferably from first-degree relative of the patient after explaining the risk of bleeding, benefits of the procedure, procedural complications, and available alternate treatment options Review laboratory reports: Complete blood counts, hemoglobin (Hb), prothrombin time/international normalized ratio (INR), urea creatinine for renal function, viral markers, activated partial thromboplastin time (APTT), and platelet counts Part preparation by shaving hair from the puncture site Doppler evaluation should be done to look for the extent of DVT, review prior computed tomography, and magnetic resonance angiography to r/o central venous thrombosis in case of upper limb DVT Prophylactic placement of a retrievable IVC filter under local anesthesia through the internal jugular vein or the femoral vein can be done in case of large thrombus load, free-floating thrombus to prevent thrombus migration into pulmonary circulation that can lead to venous thromboembolism. Figure 1 shows an in-hospital patient who developed PE despite being on anticoagulant therapy and so an IVC filter was placed to avoid further embolization. Usually, an IVC filter is not indicated in all patient who is undergoing CDT but can be placed when the patient is having risk of compromised cardiopulmonary reserve within a deadline period of 48 h if the thrombus is not resolved more than 50% and the patient is not having any significant side effects. Figure 1: IVC filter placement in L2-L3 level in patient with b/l lower limb acute DVT before initiation of CDT. IVC: Inferior vena cava, DVT: Deep vein thrombosis, CDT: Catheter-directed thrombolysisTechnique:[2,8] Vascular interventional radiologists performed the thrombolytic procedures in digital subtraction angiography (DSA) under all aseptic precaution The access site should be adequately exposed and prepared using betadine scrub and draped in a sterile fashion Infiltration of puncture site by 2% lignocaine for local anesthesia Depending on the location of thrombus, the popliteal vein or femoral vein of the affected limb is punctured using 18G puncture needle under ultrasonography guidance using high-frequency probe (8–12MHz). The patient should be in the prone position if the popliteal puncture is to be done, retrograde puncture from the contralateral femoral vein can be done in the prone position was made to perform the CDT For upper limb DVT, basilic vein and brachial vein are used If possible, there should be small length of patent vein between puncture site and thrombosed segment for placement of sheath and optimal delivery of drug in the thrombosed segment Threading of a guidewire through the 18G needle into the vein and a vascular sheath of appropriate diameter which can accommodate long vascular sheath or balloon is placed to maintain the access The venous system was navigated using 0.035-inch-diameter J tip hydrophilic guidewire, 5 F diagnostic catheter is passed over the wire, and direct venography is performed using water-soluble iodinated contrast, 5–10 ml of diluted contrast is given by hand injection, and subtraction images are obtained to estimate the severity and extent of the DVT [Figure 2a and b] Using fluoroscopic guidance, the infusion catheter is passed over the guidewire and across the treatment site A 5-Fr multiple side-hole pigtail catheter was then gently inserted over the guidewire into the thrombus [Figure 3] Thrombolytic drug is given through the pigtail catheter and aspiration of thrombus is attempted Sheath and infusion catheter are secured separately to the skin using 2.0 nonabsorbable silk sutures The infusion catheter is left in the proximal portion of thrombus and connected with a microinjection pump to start the infusion.[2,8] Figure 2: (a) Venogram taken through 5F KMP catheter using right popliteal vein access shows extensive filling defects in femoral vein, corresponding to the venous thrombosis. (b) Check venogram obtained after CDT shows good recanalization of vein with no e/o residual thrombus. CDT: Catheter-directed thrombolysis, KMP: Kumpe access catheterFigure 3: Multiple side hole 5F pigtail catheter tips in the proximal end of venous thrombus for thrombolytic infusionDose of thrombolytic to be used in CDT:[9,10] Thrombolytics that can be used in CDT are recombinant tissue plasminogen activators such as alteplase, tenecteplase, and urokinase in a dose of: Alteplase 20 mg is prepared in 500 mL of 0.9% NaCl and infusion is given in a dose of 0.01 mg/kg/h ranging between 0.5 and 1 mg/h to a maximum of 20 mg in 24 h Tenecteplase in a dose of 0.25–0.5 mg/h Urokinase in bolus dose of 200,000–300,000 IU and continuous infusion at the rate of 16000–40000 IU/h. Continuous monitoring of the patient should be done in the intensive care unit and repeated blood samples for Hb, hematocrit, APTT, and serum fibrinogen level should be taken every 10–12 h Maximum time of therapy should be 96 h Patients should be continued on unfractionated heparin 4000 IU/day subcutaneously and APTT value of 1.2–1.7 times the reference values, patient to be started on oral warfarin at a dose to keep the INR of 2–37.[9,10] Thrombolysis is stopped when:[2] Full dose of thrombolytic is administered Venography shows resolution of thrombosis and swelling is significantly reduced The two successive venogram does not any change in thrombus size Major complications occur during CDT such as excessive bleed Maximum time of CDT should be 50% thrombus load is considered successful outcome. For Venogram, Duplex should be performed for diagnosis and as well as for follow up but its subjective test can demonstrate focal lumen recanalization and thus venogram may be preferred as it is an objective test to demonstrate treatment response. Complications of Catheter-Directed Thrombolysis Infusion of thrombolysis should be stopped if any bleeding complication occurs like:[12] Intracranial hemorrhage Bleeding at the puncture site Mucosal bleeding (hematuria, vaginal bleeding, and nose bleeding) Slight pain at puncture site.[12] Conclusion CDT must be judiciously used in patients of DVT for preventing complications keeping in mind all the contraindications and side effects. This article provides a brief review of all the practical details pertaining to the use of CDT. Guarantor SKR is the guarantor of the present work. Author Contribution SKR: Concept, design, literature search, data analysis, manuscript preparation. PS: Design, Data acquisition, manuscript review. Financial support and sponsorship Nil. Conflicts of interest There are no conflicts of interest.
Zitieren
APA
Rai, S. K., & Sharma, P. (2024). Practical considerations for the use of catheter-directed thrombolysis in deep vein thrombosis. Vascular Investigation and Therapy. https://doi.org/10.4103/vit.vit-d-23-00007
Vancouver
Rai SK, Sharma P. Practical considerations for the use of catheter-directed thrombolysis in deep vein thrombosis. Vascular Investigation and Therapy. 2024. doi:10.4103/vit.vit-d-23-00007
BibTeX
@article{Rai2024,
author = {Rai, Saurabh Kumar and Sharma, Pankaj},
title = {Practical considerations for the use of catheter-directed thrombolysis in deep vein thrombosis},
journal = {Vascular Investigation and Therapy},
year = {2024},
doi = {10.4103/vit.vit-d-23-00007}
}
EUVIMED